Table 2.
Category of test | Concentration | Bacteria | |||
---|---|---|---|---|---|
S. flexneri | E. coli | ||||
Stand | Clinic | Stand | clinic | ||
Crude | 19.5 mg/well | 12.00 ± 0.58a3d2 | 11.67 ± 0.33 a3d2 | 11.67 ± .88a3d1 | 11.33 ± 0.67a3d2 |
39 mg/well | 14.00 ± 0.00a3d1 | 13.67 ± 0.33 a3d1 | 12.67 ± 0.33a3 | 12.67 ± 0.33a3 | |
78 mg/well | 17.00 ± 0.58a3 | 16.00 ± 0.58 a3 | 15.00 ± 0.00a3 | 14.50 ± 0.29 a3 | |
Cef 0.03 mg/disc* | NT | NT | 28.33 ± 0.88 | 27.00 ± 0.58 | |
Cip 0.005 mg/disc* | 26.33 ± 0.67 | 25.00 ± 0.58 | NT | NT | |
Methanol | 19.5 mg/well | 11.00 ± 0.00a3d2 | 10.67 ± 0.67a3d2 | 10.33 ± 0.33a3d3 | 9.00 ± 0.58a3c2d3 |
39 mg/well | 13.00 ± 0.58a3 | 12.67 ± 0.33a3 | 12.00 ± 0.58a3d1 | 11.67 ± 0.33a3d2 | |
78 mg/well | 15.00 ± 0.58a3 | 14.67 ± 0.33a3 | 14.50 ± 0.29a3 | 14.33 ± 0.33a3 | |
Cef 0.03 mg/disc* | NT | NT | 27.67 ± 0.33 | 26.67 ± 0.33 | |
Cip 0.005 mg/disc* | 27.00 ± 0.58 | 26.33 ± 0.67 | NT | NT | |
Chloroform | 19.5 mg/well | 10.00 ± 0.58a3d2 | 10.33 ± 0.33a3 | --- | --- |
39 mg/well | 11.33 ± 0.33a3f1 | 11.67 ± 0.67a3 | ---- | --- | |
78 mg/well | 13.33 ± 0.33 a3g2 | 12.33 ± 0.33a3g2 | --- | --- | |
Cip 0.005 mg/disc* | 25.00 ± 0.58 | 24.67 ± 0.33 | NT | NT |
Values are expressed as Mean ± S.E.M (n = 3), analysis was performed with One-Way ANOVA followed by Tukey test acompared positive control, bto 19.5 mg/well, cto 39 mg/well, dto 78 mg/well, eto crude 19.5 mg/well, fto crude 39 mg/well, gto crude 78 mg/well; 1 P < 0.05, 2 P < 0.01, 3 P < 0.001. The negative control has shown no antibacterial activity. * = positive controls, Stand = standard (ATCC) strains whereas Clinic. = clinically isolated strains, NT = not tested, Cef = Cefoxitin, Cip = Ciprofloxacin, --- = no activitiy